Sector

Healthcare ETFs

Funds with most of their holdings in the Healthcare sector. Pick one to see news about the companies inside it.

AGNGGlobal X Aging Population
Quartz · 28 Oct 2026, 16:16 UTC
Best-selling drugs 2026: 7 of the top 10 by 2025 sales
13.3% of AGNGMore AGNG news →
ARKGARK Genomic Revolution
Seeking Alpha · 28 Oct 2026, 20:19 UTC
10x Genomics: Atera Takes Off, But Valuation Flies Too High (NASDAQ:TXG) | Seeking Alpha
9.4% of ARKGMore ARKG news →
AZNHAstraZeneca PLC ADRhedged
wallstreet:online · 28 Oct 2026, 12:05 UTC
AstraZeneca and Mark-Paul Gosselaar Launch Meet Your Mark to Raise Awareness of Cancer Biomarker Testing
99.4% of AZNHMore AZNH news →
BBHVanEck Biotech
Quartz · 28 Oct 2026, 14:15 UTC
New weight-loss drugs: what 6 drugmakers are testing
15.2% of BBHMore BBH news →
BBPVirtus LifeSci Biotech Products
24/7 Wall St. · 28 Oct 2026, 16:04 UTC
Moderna Jumps 4% Despite William Blair Downgrade on Valuation; Novavax and BioNTech Edge Higher
4.0% of BBPMore BBP news →
BMEDiShares Health Innovation Active
TheStreet · 28 Oct 2026, 19:33 UTC
Breakthrough cancer vaccine catches Wall Street's attention
8.8% of BMEDMore BMED news →
CANCTema Oncology
Quartz · 28 Oct 2026, 16:16 UTC
Best-selling drugs 2026: 7 of the top 10 by 2025 sales
11.7% of CANCMore CANC news →
EKGFirst Trust Nasdaq Lux Digital Health Solutions
Investing.com · 28 Oct 2026, 22:30 UTC
Intuitive Surgical EVP Mark Brosius sells $82,043 in company stock By Investing.com
6.0% of EKGMore EKG news →
FBTFirst Trust NYSE Arca Biotechnology Index Fund
Scienmag: Latest Science and Health News · 28 Oct 2026, 18:47 UTC
Nanopore Sequencing Delivers Full Pediatric Brain Tumor Workup in a Single
3.9% of FBTMore FBT news →
FHLCFidelity MSCI Health Care Index
Yahoo! Finance · 28 Oct 2026, 07:29 UTC
The Zacks Analyst Blog Highlights Eli Lilly, Novartis, Johnson & Johnson and AbbVie
28.7% of FHLCMore FHLC news →
FMEDFidelity Disruptive Medicine
Seeking Alpha · 28 Oct 2026, 20:19 UTC
10x Genomics: Atera Takes Off, But Valuation Flies Too High (NASDAQ:TXG) | Seeking Alpha
5.2% of FMEDMore FMED news →
FTXHFirst Trust Nasdaq Pharmaceuticals
Quartz · 28 Oct 2026, 16:16 UTC
Best-selling drugs 2026: 7 of the top 10 by 2025 sales
24.1% of FTXHMore FTXH news →
FXHFirst Trust Health Care Alphadex Fund
Quartz · 28 Oct 2026, 12:37 UTC
10 Medicare Advantage insurer ratings for 2027 across 4 categories
6.9% of FXHMore FXH news →
GDOCGoldman Sachs Future Health Care Equity
Quartz · 28 Oct 2026, 16:16 UTC
Best-selling drugs 2026: 7 of the top 10 by 2025 sales
19.6% of GDOCMore GDOC news →
GNOMGlobal X Genomics & Biotechnology
24/7 Wall St. · 28 Oct 2026, 16:04 UTC
Moderna Jumps 4% Despite William Blair Downgrade on Valuation; Novavax and BioNTech Edge Higher
6.7% of GNOMMore GNOM news →
GSKHGSK plc ADRhedged
No recent stories
More GSKH news →
HEALGlobal X HealthTech
Financial Post · 28 Oct 2026, 00:00 UTC
How Brands Do Agentic Marketing Today: Lessons From the 2026 Contentstack Experience Award Winners
4.1% of HEALMore HEAL news →
HELXFranklin Genomic Advancements
Seeking Alpha · 28 Oct 2026, 17:33 UTC
Ligand Pharmaceuticals Q3 2026 Earnings Preview | Seeking Alpha
4.6% of HELXMore HELX news →
HRTSTema Heart & Health
Quartz · 28 Oct 2026, 16:16 UTC
Best-selling drugs 2026: 7 of the top 10 by 2025 sales
23.1% of HRTSMore HRTS news →
HTECROBO Global(R) Healthcare Technology and Innovation
24/7 Wall St. · 28 Oct 2026, 22:00 UTC
Thermo Fisher Scientific Reaches $704 and a New 52-Week High
2.2% of HTECMore HTEC news →
IBBiShares Biotechnology
Quartz · 28 Oct 2026, 14:15 UTC
New weight-loss drugs: what 6 drugmakers are testing
7.8% of IBBMore IBB news →
IBBQInvesco Nasdaq Biotechnology
Quartz · 28 Oct 2026, 14:15 UTC
New weight-loss drugs: what 6 drugmakers are testing
7.1% of IBBQMore IBBQ news →
IBRNiShares Neuroscience and Healthcare
Seeking Alpha · 28 Oct 2026, 20:02 UTC
Biogen anticipates $250M of run rate synergies by end of 2027 as it raises 2026 non-GAAP EPS to $12.20-$13 (NASDAQ:BIIB) | Seeking Alpha
4.2% of IBRNMore IBRN news →
IDNAiShares Genomics Immunology and Healthcare
24/7 Wall St. · 28 Oct 2026, 16:04 UTC
Moderna Jumps 4% Despite William Blair Downgrade on Valuation; Novavax and BioNTech Edge Higher
13.1% of IDNAMore IDNA news →
IHEiShares U.S. Pharmaceuticals
Quartz · 28 Oct 2026, 16:16 UTC
Best-selling drugs 2026: 7 of the top 10 by 2025 sales
35.1% of IHEMore IHE news →
IHFiShares U.S. Healthcare Providers
Quartz · 28 Oct 2026, 12:37 UTC
10 Medicare Advantage insurer ratings for 2027 across 4 categories
33.7% of IHFMore IHF news →
IHIiShares U.S. Medical Devices
Yahoo! Finance · 28 Oct 2026, 22:09 UTC
Apple Stock And Other Quality Growth Names For Higher Rates
16.9% of IHIMore IHI news →
IXJiShares Global Healthcare
Yahoo! Finance · 28 Oct 2026, 07:29 UTC
The Zacks Analyst Blog Highlights Eli Lilly, Novartis, Johnson & Johnson and AbbVie
26.8% of IXJMore IXJ news →
IYHiShares U.S. Healthcare
Yahoo! Finance · 28 Oct 2026, 07:29 UTC
The Zacks Analyst Blog Highlights Eli Lilly, Novartis, Johnson & Johnson and AbbVie
32.6% of IYHMore IYH news →
JDOCJPMorgan Healthcare Leaders
Quartz · 28 Oct 2026, 16:16 UTC
Best-selling drugs 2026: 7 of the top 10 by 2025 sales
18.8% of JDOCMore JDOC news →
LGHTLangar Global HealthTech
Investing.com · 28 Oct 2026, 22:30 UTC
Intuitive Surgical EVP Mark Brosius sells $82,043 in company stock By Investing.com
9.9% of LGHTMore LGHT news →
MDEVFirst Trust Indxx Medical Devices
Seeking Alpha · 29 Oct 2026, 02:00 UTC
Align Technology, Inc. (ALGN) Q3 2026 Earnings Call Transcript
2.0% of MDEVMore MDEV news →
MEDIHarbor Health Care
Quartz · 28 Oct 2026, 16:16 UTC
Best-selling drugs 2026: 7 of the top 10 by 2025 sales
24.7% of MEDIMore MEDI news →
MEDXHorizon Kinetics Medical
Yahoo! Finance · 28 Oct 2026, 07:29 UTC
The Zacks Analyst Blog Highlights Eli Lilly, Novartis, Johnson & Johnson and AbbVie
39.8% of MEDXMore MEDX news →
MJAmplify Alternative Harvest
Seeking Alpha · 27 Oct 2026, 20:00 UTC
SNDL Inc. (SNDL) Q3 2026 Earnings Call Transcript | Seeking Alpha
6.3% of MJMore MJ news →
MULTFranklin Multisector Income
Seeking Alpha · 28 Oct 2026, 17:33 UTC
Ligand Pharmaceuticals Q3 2026 Earnings Preview | Seeking Alpha
4.6% of MULTMore MULT news →
NVOHNovo Nordisk A/S (B Shares) ADRhedged
Quartz · 28 Oct 2026, 17:20 UTC
Lilly's retatrutide more than doubled Ozempic weight loss in trial
96.9% of NVOHMore NVOH news →
OZEMRoundhill GLP-1 & Weight Loss
Quartz · 28 Oct 2026, 14:15 UTC
New weight-loss drugs: what 6 drugmakers are testing
35.9% of OZEMMore OZEM news →
PBEInvesco Biotechnology & Genome
Scienmag: Latest Science and Health News · 28 Oct 2026, 18:47 UTC
Nanopore Sequencing Delivers Full Pediatric Brain Tumor Workup in a Single
5.4% of PBEMore PBE news →
PINKSimplify Health Care
Quartz · 28 Oct 2026, 14:15 UTC
New weight-loss drugs: what 6 drugmakers are testing
14.8% of PINKMore PINK news →
PJPInvesco Pharmaceuticals
Quartz · 28 Oct 2026, 16:16 UTC
Best-selling drugs 2026: 7 of the top 10 by 2025 sales
17.5% of PJPMore PJP news →
PPHVanEck Pharmaceutical
Quartz · 28 Oct 2026, 16:16 UTC
Best-selling drugs 2026: 7 of the top 10 by 2025 sales
44.4% of PPHMore PPH news →
PSCHInvesco S&P SmallCap Health Care
Seeking Alpha · 28 Oct 2026, 17:33 UTC
Ligand Pharmaceuticals Q3 2026 Earnings Preview | Seeking Alpha
2.4% of PSCHMore PSCH news →
PTHInvesco Dorsey Wright Healthcare Momentum
Market Screener · 28 Oct 2026, 12:21 UTC
United Therapeutics Corporation Receives FDA Clearance To Proceed With Clinical Trial For Treprostinil-Iloprost SMI In Pulmonary Arterial Hypertension
3.4% of PTHMore PTH news →
QOWZInvesco Nasdaq Free Cash Flow Achievers
Quartz · 28 Oct 2026, 14:15 UTC
New weight-loss drugs: what 6 drugmakers are testing
7.1% of QOWZMore QOWZ news →
RSPHInvesco S&P 500 Equal Weight Health Care
Quartz · 28 Oct 2026, 16:16 UTC
Best-selling drugs 2026: 7 of the top 10 by 2025 sales
6.9% of RSPHMore RSPH news →
RXLProShares Ultra Health Care
Quartz · 28 Oct 2026, 16:16 UTC
Best-selling drugs 2026: 7 of the top 10 by 2025 sales
20.8% of RXLMore RXL news →
THNRAmplify Weight Loss Drug & Treatment
Quartz · 28 Oct 2026, 16:16 UTC
Best-selling drugs 2026: 7 of the top 10 by 2025 sales
28.0% of THNRMore THNR news →
TMEDT. Rowe Price Health Care
Quartz · 28 Oct 2026, 16:16 UTC
Best-selling drugs 2026: 7 of the top 10 by 2025 sales
18.6% of TMEDMore TMED news →
VHTVanguard Health Care Index Fund
Quartz · 28 Oct 2026, 16:16 UTC
Best-selling drugs 2026: 7 of the top 10 by 2025 sales
22.9% of VHTMore VHT news →

European (UCITS) Healthcare funds

We show news for a similar US-listed fund.